A former director of Chinook Therapeutics Inc. tipped off family and friends who traded stock ahead of an announcement that ...

Wes Streeting has walked away from talks with pharmaceutical giants on NHS drug costs amid a stand-off over rebates.

Multiple sclerosis (MS) has long been regarded as a disease with different subtypes such as "relapsing" or "progressive." An international study, published on August 20, 2025, in Nature Medicine under ...

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy ...

Deutsche Bank raised the firm’s price target on Novartis (NVS) to CHF 120 from CHF 115 and keeps a Buy rating on the shares. Published first on ...

While phase 1 data suggest the novel vaccine can boost immunity and reduce relapse in pancreatic and colorectal cancer, experts remain cautious at this initial stage.

The development of the new malaria medicine from the Basel-based pharmaceutical company Novartis for babies weighing 4½ to 11 pounds has given hope to many, with health workers in Nigeria, Congo and ...

In people with recently diagnosed type 2 diabetes and no prior cardiovascular disease, self-reported physical activity ...

As the Trump administration upends federal research, Mizzou aims to raise more than $1 billion to build an advanced nuclear reactor to accelerate production of key ingredients for cancer treatments.

An artificial intelligence (AI)-assisted model that combines a patient’s MRI, biochemical, and clinical information shows ...

In vivo CAR T-cell therapies promise to revolutionize cancer treatment, enhancing access and reducing costs while addressing ...